UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Neurology, ISSN 0028-3878, 10/2018, Volume 91, Issue 17, pp. 771 - 773
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 09/2020, Volume 91, Issue 9, pp. 914 - 920
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Prospective Studies | Humans | Middle Aged | Male | Treatment Outcome | Withholding Treatment - statistics & numerical data | Patient Compliance - statistics & numerical data | Time Factors | Adult | Female | Cannabidiol - therapeutic use | Dronabinol - therapeutic use | Drug Combinations | Multiple Sclerosis - drug therapy | Multiple sclerosis | Statistical analysis | Clinical trials | Spasticity | Cannabidiol | Regression analysis | Patients | Variance analysis | Studies | Variables | Tetrahydrocannabinol--THC | Software | Clinical medicine | Age | Index Medicus
Journal Article
Neurological sciences, ISSN 1590-1874, 01/2021
Journal Article
Multiple sclerosis, ISSN 1352-4585, 8/2019, Volume 25, Issue 9, pp. 1306 - 1315
predictors | Multiple sclerosis | MRI | relapse | disability | age | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Clinical trials | Nuclear magnetic resonance--NMR | Magnetic resonance imaging | Age | Index Medicus | Original Research Papers
Journal Article
Multiple sclerosis, ISSN 1352-4585, 10/2015, Volume 21, Issue 11, pp. 1463 - 1467
relapsing–remitting | relapsing-remitting | multiple sclerosis | genetic risk | weighted genetic risk score | Primary-progressive | age of onset | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Multiple Sclerosis, Chronic Progressive - physiopathology | Genetic Predisposition to Disease | Humans | Middle Aged | Male | Risk | Multiple Sclerosis, Relapsing-Remitting - physiopathology | Multiple Sclerosis, Chronic Progressive - epidemiology | Disease Progression | Young Adult | Adolescent | Age of Onset | Multiple Sclerosis, Relapsing-Remitting - epidemiology | Adult | Female | Italy - epidemiology | Aged | Child | Cohort Studies | Index Medicus
Journal Article
Annals of neurology, ISSN 0364-5134, 11/2017, Volume 82, Issue 5, pp. 697 - 705
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Disability Evaluation | Immune Reconstitution Inflammatory Syndrome - prevention & control | Leukoencephalopathy, Progressive Multifocal - therapy | Humans | Immune Reconstitution Inflammatory Syndrome - complications | Leukoencephalopathy, Progressive Multifocal - drug therapy | Male | Young Adult | Immune Reconstitution Inflammatory Syndrome - drug therapy | Immune Reconstitution Inflammatory Syndrome - therapy | Adult | Female | Plasma Exchange - adverse effects | Retrospective Studies | Steroids - therapeutic use | Databases, Factual | Leukoencephalopathy, Progressive Multifocal - complications | Steroids - adverse effects | Immune reconstitution | Data processing | Inflammation | Variance analysis | Patients | Leukoencephalopathy | Steroid hormones | Steroids | Progressive multifocal leukoencephalopathy | Latency | Index Medicus
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 03/2019, Volume 90, Issue 3, pp. 261 - 267
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Humans | Middle Aged | Male | Multiple Sclerosis - diagnostic imaging | Young Adult | Magnetic Resonance Imaging | Natalizumab - therapeutic use | Leukoencephalopathy, Progressive Multifocal - etiology | Multiple Sclerosis - pathology | Adult | Female | Italy | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Leukoencephalopathy, Progressive Multifocal - pathology | Retrospective Studies | Early Diagnosis | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy | Neurology | Multiple sclerosis | Nuclear magnetic resonance--NMR | Brain research | Surveillance | Laboratories | Medical diagnosis | Patients | Index Medicus
Journal Article
8.
Full Text
Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
Journal of neuropathology and experimental neurology, ISSN 0022-3069, 05/2009, Volume 68, Issue 5, pp. 489 - 502
Basal ganglia | Caudate | Multiple sclerosis | Neuronal loss | Excitotoxicity | Thalamus | Gray matter | Pathology | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Injuries of the nervous system and the skull. Diseases due to physical agents | Neurology | Biological and medical sciences | Medical sciences | Traumas. Diseases due to physical agents | Inflammation - pathology | Neurons - pathology | Neurodegenerative Diseases - etiology | Neuroglia - pathology | Humans | Middle Aged | Male | Antigens, CD - metabolism | Inflammation - complications | Adult | Female | Demyelinating Diseases - etiology | Demyelinating Diseases - pathology | HLA-DR Antigens - metabolism | Neurodegenerative Diseases - pathology | Myelin Basic Protein - metabolism | Amyotrophic Lateral Sclerosis - complications | Multiple Sclerosis - complications | Nerve Tissue Proteins - metabolism | Amyotrophic Lateral Sclerosis - pathology | Staining and Labeling | Fibrinogen - metabolism | Brain - pathology | Multiple Sclerosis - pathology | Aged | Index Medicus
Journal Article
Multiple sclerosis, ISSN 1352-4585, 7/2018, Volume 24, Issue 8, pp. 1133 - 1137
histopathology | post mortem | Fingolimod | glia | demyelination | multiple sclerosis | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Multiple Sclerosis, Relapsing-Remitting - pathology | Recurrence | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Astrocytes - pathology | Brain - metabolism | Autopsy | Fatal Outcome | Brain - pathology | Adult | Fingolimod Hydrochloride - therapeutic use | Multiple Sclerosis, Relapsing-Remitting - metabolism | Receptors, Lysosphingolipid - biosynthesis | Astrocytes - metabolism | Multiple sclerosis | Gliosis | Magnetic resonance imaging | Neuropathology | Astrocytes | Demyelination | Substantia alba | Sphingosine 1-phosphate | Index Medicus
Journal Article
6/2020, Volume 13, 30
Book Review